Two Decades of Data Reveal How Small Molecule Drugs Reshaped Lung Cancer Treatment
A two-decade bibliometric analysis of nearly 5,000 studies maps how small molecule drug research transformed lung cancer therapy, revealing China's ...
A two-decade bibliometric analysis of nearly 5,000 studies maps how small molecule drug research transformed lung cancer therapy, revealing China's ...
A Johns Hopkins study of 69 patients maps intradural spinal metastasis as a late stage of cancer spread, showing median ...
Researchers in Düsseldorf report that co-expressing a non-signaling EGFR-binding CAR alongside EGFRvIII-specific CAR T-cells enhances killing of head and neck ...
A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...
A Cornell clinical trial found that the oral MEK inhibitor trametinib shrank or stabilized oral squamous cell carcinoma tumors in ...
A new mouse study shows that lung adenocarcinomas can evade KRAS inhibitors by reprogramming their cellular identity through transcription factors ...
Researchers in Japan used organoid-line-specific regulatory network analysis on patient-derived colorectal cancer organoids to uncover drug-response-associated subnetworks that conventional biomarkers ...
A new review in the Journal of Ovarian Research details how chronic inflammatory signaling pathways drive ovarian cancer progression and ...
A phase 1b/2 trial found that the oral CBP–β-catenin inhibitor E7386 combined with lenvatinib produced durable responses in advanced endometrial ...
A study of 140 liver tumor samples shows that Glypican-3 and AXL are co-expressed in nearly all hepatocellular carcinomas, supporting ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine